| Fatigue | Sleep disturbance | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Not triggered % (N) | Trigger level 1% (N) | Trigger level 2% (N) | Chi-square (df) | p Value | Not triggered % (N) | Trigger level 1% (N) | Trigger level 2% (N) | Chi-square (df) | p Value | |
Age groups | ||||||||||
18-44 | 31 (62) | 40.0 (80) | 29.0 (58) | 23.2 (8) | 0.003 | 62.8 (135) | 12.1 (26) | 25.1 (54) | 74.7 (8) | <.0001 |
45-64 | 26.3 (396) | 36.3 (547) | 37.4 (564) | Â | Â | 66.2 (1,055) | 12.1 (192) | 21.7 (346) | Â | Â |
65-74 | 27.5 (351) | 31.8 (406) | 40.7 (520) | Â | Â | 73.6 (1,015) | 11.5 (159) | 14.9 (206) | Â | Â |
75-84 | 25.7 (364) | 34.4 (487) | 39.9 (565) | Â | Â | 76.8 (1,187) | 10.0 (154) | 13.3 (205) | Â | Â |
85 + | 24.5 (136) | 30.6 (170) | 44.9 (249) | Â | Â | 74.5 (462) | 13.1 (81) | 12.4 (77) | Â | Â |
Gender | ||||||||||
Male | 25.3 (607) | 33.9 (815) | 40.9 (982) | 4.7 (2) | 0.09 | 69.5 (1,813) | 13.3 (346) | 17.2 (449) | 20.2 (2) | <.0001 |
Female | 27.6 (693) | 34.2 (860) | 38.2 (960) | Â | Â | 74.3 (2,014) | 9.7 (263) | 16.0 (433) | Â | Â |
Estimated prognosis | ||||||||||
Death imminent | 2.5 (2) | 8.9 (7) | 88.6 (70) | 856.8 (6) | <.0001 | 68.8 (53) | 9.1 (7) | 22.1 (17) | 23.1 (6) | 0.0008 |
Less than 6Â weeks | 3.8 (15) | 25.3 (99) | 70.8 (277) | Â | Â | 75.3 (289) | 5.0 (19) | 19.8 (76) | Â | Â |
6Â weeks to 6Â months | 14.1 (337) | 41.9 (1,000) | 44.0 (1,052) | Â | Â | 71.5 (1,635) | 11.2 (257) | 17.3 (394) | Â | Â |
Greater than 6Â months | 45.6 (955) | 27.9 (584) | 26.6 (557) | Â | Â | 72.0 (1,483) | 12.5 (258) | 15.5 (320) | Â | Â |
Geographic location | ||||||||||
Site 1 | 19.5 (50) | 35.2 (90) | 45.3 (116) | 202.3 (10) | <.0001 | 76.5 (199) | 6.9 (18) | 16.5 (43) | 31.6 (10) | 0.0005 |
Site 2 | 28.9 (868) | 28.7 (860) | 42.4 (1,273) | Â | Â | 73.1 (2,499) | 11.5 (393) | 15.5 (529) | Â | Â |
Site 3 | 28.5 (262) | 45.1 (415) | 26.5 (244) | Â | Â | 67.1 (633) | 13.8 (130) | 19.09 (180) | Â | Â |
Site 4 | 15.8 (70) | 40.3 (178) | 43.9 (194) | Â | Â | 70.8 (312) | 7.9 (35) | 21.32 (94) | Â | Â |
Site 5 | 18.0 (20) | 64.0 (71) | 18.0 (20) | Â | Â | 73.9 (68) | 12.0 (11) | 14.13 (13) | Â | Â |
Site 6 | 17.4 (39) | 33.9 (76) | 48.7 (109) | Â | Â | 72.6 (143) | 12.7 (25) | 14.72 (29) | Â | Â |
Diagnosis | ||||||||||
Have cancer diagnosis | 28.1 (823) | 34.7 (1,016) | 37.2 (1,090) | 94.2 (6) | <.0001 | 73.6 (2,360) | 11.3 (362) | 15.1 (484) | 19.8 (6) | 0.003 |
Have cancer and non-cancer diagnosis | 26.2 (375) | 37.1 (530) | 36.7 (525) | Â | Â | 68.8 (1,038) | 11.9 (180) | 19.28 (291) | Â | Â |
Have non-cancer diagnosis only | 17.2 (79) | 24.8 (114) | 58.0 (266) | Â | Â | 71.2 (349) | 9.8 (48) | 18.98 (93) | Â | Â |
Diagnosis unspecified | 23.4 (32) | 21.9 (30) | 54.7 (75) | Â | Â | 71.8 (107) | 14.8 (22) | 13.4 (20) | Â | Â |